Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Chagas disease
2010 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Infective Endocarditis
2005 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease
1992
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation
1993
Antithrombotic Therapy in Valvular Heart Disease
1998
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Skin electronics from scalable fabrication of an intrinsically stretchable transistor array
2018 StandoutNature
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Guidelines for the Primary Prevention of Stroke
2010
Modern Management of Prosthetic Valve Anticoagulation
1998
Atrial fibrillation. Cause and time of onset
1989
Williams–Beuren Syndrome
2010 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Myocarditis
2011 Standout
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
1996 Standout
Incidence of left atrial thrombi in patients in sinus rhythm and with a recent neurologic deficit
2000
Current and evolving treatment strategies for the Alzheimer disease continuum
2020
Burden of valvular heart diseases: a population-based study
2006 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
Is Atrial Fibrillation an Independent Risk Factor for Stroke?
1990
Antithrombotic and Thrombolytic Therapy for Valvular Disease
2012
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Antithrombotic Therapy in Valvular Heart Disease
2001
Myocarditis
2009 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Stretchable E‐Skin Apexcardiogram Sensor
2016
Lecanemab in Early Alzheimer’s Disease
2022 Standout
On the Mechanism of the Austin Flint Murmur
1972
Open mitral valvotomy
1981
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
1991 Standout
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
1998
Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients.
1983
Cerebral embolism and mitral stenosis: survival with and without anticoagulants
1974
Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
1986
Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound
1986
Antithrombotic Therapy in Valvular Heart Disease
1995
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Clinical features of intracardiac thrombosis based on echocardiographic observation.
1984
Relation between echocardiographically determined left atrial size and atrial fibrillation.
1976
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Antithrombotic Therapy in Atrial Fibrillation
1989
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
Afterload reduction therapy with nitroprusside in severe aortic regurgitation: Improved cardiac performance and reduced regurgitant volume
1976
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
The Austin Flint Murmur and the a Wave of the Apexcardiogram in Aortic Regurgitation
1971
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Calcification of the mitral annulus
1979
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Thromboembolism and Antithrombotic Therapy in Congestive Heart Failure
1995
Prolapsed mitral valve: The commonest valve disease?
1984
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1993 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study
1994 Standout
Echography and Phonography of Acute Aortic Regurgitation in Bacterial Endocarditis
1975
Familial Supravalvular Aortic Stenosis
1976
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis
1996
Left Atrial Size and the Risk of Stroke and Death
1995
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
1975
Evidence for Cardiomyopathy in Familial Diabetes Mellitus
1977
Incidence of systemic embolism before and after mitral valvotomy
1968
Antithrombotic Therapy in Atrial Fibrillation
1992
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
The systolic click-murmur syndrome: Clinical recognition and management
1976
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
The management of anticoagulation in patients with prosthetic heart valves undergoing non-cardiac operations
1995
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Cardiac thrombosis and thromboembolism in chronic chagas' heart disease
1983
Influence of etiology of atrial fibrillation on incidence of systemic embolism
1977
Works of Eric J. Epstein being referenced
Systemic Embolism in Mitral Stenosis
1964
FAMILIAL SUPRAVALVAR AORTIC STENOSIS
1965
Haemodynamic changes after angiocardiography.
1969
Phonocardiogram and apex cardiogram in systolic click--late systolic murmur syndrome.
1973
Duration of phases of left ventricular systole using indirect methods. II. Acute myocardial infarction.
1972
Drugs for cognitive loss and dementia.
2007
Systemic embolism in mitral valve disease.
1970
Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome.
1981
The 'A' wave of the apex cardiogram in aortic valve disease and cardiomyopathy.
1968
HAeMODYNAMIC EFFECTS OF SEVERE AORTIC REGURGITATION
1964
THE APEX CARDIOGRAM: ITS NORMAL FEATURES EXPLAINED BY THOSE FOUND IN HEART DISEASE
1963